Insights On Pharmaceutical Packaging
-
Oral Solid Dosage Products: Water Activity And Primary Packaging Selection
7/17/2022
Every individual oral solid dosage (OSD) product has different water activity initially and over time. Learn about USP <922> water activity and primary packaging selection of OSD products.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
10/20/2023
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Faster From Formulation To Fill/Finish
7/12/2022
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
Societalâ„¢ CDMO Capacity Update June 2023: Small Molecule
6/21/2023
Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
-
Meeting An Aggressive Go-To-Clinic Timeline
9/27/2023
Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.
-
The Advantages Of Blow/Fill/Seal Processing For Vaccine Production
8/18/2023
Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. Learn how B/F/S systems can be adapted for vaccine production without incurring any product degradation.
-
The Ultimate Guide To Clinical Supplies For Japan Studies
7/14/2022
Catalent's local team in Japan provides comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, and local and global distribution.
-
A Risk-Based Approach To Injectable Combination Product Development
3/14/2023
Examine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.
-
Delivering On GLP-1 Demand: Combining Device And Supply Strategy
5/7/2024
Meeting the surge in demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions, including the Alina® pen injector platform and Aidaptus® auto-injector platform, offer customization, streamlined manufacturing, and compatibility with various drug formulations.
-
The Use Of Injectable Packaging From Early Development To Commercialization
2/20/2024
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.